博实股份2024年第三季度报告(英文版)

HARBIN BOSHI AUTOMATION CO., LTD. Interim Report for the Third Quarter 2024 1 HARBIN BOSHI AUTOMATION CO., LTD. Interim Report for The Third Quarter 2024 The Company and whole members of the Board of Directors guarantee that the information disclosed is factual, accurate and complete, and there is no false record, misleading statement or material omission. Important content reminder: 1.The Board of Directors, the Board of Supervisors as well as all the directors, supervisors and senior managers of HARBIN BOSHI AUTOMATION CO., LTD. (hereinafter referred to as “the Company”) warrant the factuality, accuracy and completeness of this Report and there is no false record, misleading statement or material omission. And they will be severally and jointly liable for this Report. 2.The person in charge of the Company, the person in charge of accounting work of the Company, and the person in charge of accounting department of the Company warrant that the financial information in this Report is factual, accurate and complete. 3. Whether this Third Interim Report has been audited by auditing firm or not? □Yes √No HARBIN BOSHI AUTOMATION CO., LTD. Interim Report for the Third Quarter 2024 2 I. Main financial data 1. Main accounting data and financial indicators Indicate by check mark if there is any retrospectively restated accounting data of previous years. □Yes √No Current period Increase/decrease in the period compared with the same period of the previous year Year-begin to period-end Increase/decrease from year-begin to period-end compared with the same period of the previous year Operating Revenue (RMB) 712,735,460.01 20.21% 2,164,678,881.70 9.20% Net profit attributable to parent company’s shareholders (RMB) 183,508,513.17 85.12% 456,225,297.69 4.98% Net profit after deducting non-recurring profit or loss attributable to shareholders of the parent company (RMB) 174,848,694.35 90.13% 431,574,091.35 7.40% Net cash flow from operating activities (RMB) —— —— 447,884,786.41 8,352.29% Basic earnings per share (RMB /share) 0.1807 86.48% 0.4491 5.67% Diluted earnings per share (RMB /share) 0.1786 84.31% 0.4451 5.47% Weighted average return on equity 5.11% 2.11% 12.69% -0.57% End of the current reporting period End of previous year Increase/decrease at the period-end compared with the end of the previous year Total assets (RMB) 6,640,391,547.82 6,648,692,787.99 -0.12% Total equity attributable to shareholders of the parent company (RMB) 3,684,584,455.30 3,450,338,131.69 6.79% HARBIN BOSHI AUTOMATION CO., LTD. Interim Report for the Third Quarter 2024 3 2. Non-recurring gains and losses √ Applicable □Not applicable Unit: RMB Item Amount for the period Amount from year-begin to period-end Note Profit or loss from disposal of non-current assets (including the write-off of accrued for impairment of assets) -13,088.68 -529,474.76 Governmental subsidy reckoned into current gains or losses (excluding the subsidy enjoyed

立即下载
综合
2024-10-30
15页
0.65M
收藏
分享

博实股份2024年第三季度报告(英文版),点击即可下载。报告格式为PDF,大小0.65M,页数15页,欢迎下载。

本报告共15页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
本报告共15页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
水滴研报所有报告均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
相关图表
图 10 样本创新药年涨跌幅度(%)
综合
2024-10-29
来源:创新药行业周报:国谈启动,关注相关品种纳入医保放量投资机会
查看原文
图 7 样本创新药周涨幅 TOP10(%) 图 8 样本创新药周跌幅 TOP10(%)
综合
2024-10-29
来源:创新药行业周报:国谈启动,关注相关品种纳入医保放量投资机会
查看原文
图 5 美国十年期国债收益率(%) 图 6 近期美国十年期国债收益率(%)
综合
2024-10-29
来源:创新药行业周报:国谈启动,关注相关品种纳入医保放量投资机会
查看原文
图 3 国内生物科技指数 PB 图 4 恒生生物科技指数 PB
综合
2024-10-29
来源:创新药行业周报:国谈启动,关注相关品种纳入医保放量投资机会
查看原文
图 1 国内外主要市场生科指数周涨跌幅(%) 图 2 全球主要生物科技指数近一年走势
综合
2024-10-29
来源:创新药行业周报:国谈启动,关注相关品种纳入医保放量投资机会
查看原文
环保行业重点推荐组合基本数据一览
综合
2024-10-29
来源:环保行业周报:完善碳排放统计核算体系工作方案出台,奠定全国范围碳排放双控基础
查看原文
回顶部
报告群
公众号
小程序
在线客服
收起